Latest Sirolimus Stories
PINEHURST, N.C., Feb.
-- Novel Drug-delivery Technology Provides Sirolimus-Eluting Stent with Unique Bioabsorbable Polymer Absorption and Drug Release Profile -- DURHAM, N.C., Feb.
-- Distribution Agreement Secured with STENTYS -- DURHAM, N.C., Nov. 3, 2014 /PRNewswire/ -- Micell Technologies, Inc.
DALLAS, October 17, 2014 /PRNewswire/ -- The Middle East and Africa Solid Organ Transplant Immunosuppressant Industry 2014 Deep Research Report is of 120 pages and published
WASHINGTON, September 18, 2014 /PRNewswire/ -- The world's first and only dual therapy stent Prof. Stephen W.L.
-- Differentiated Design Yields Excellent Tissue Healing and Sustained Safety Profile -- DURHAM, N.C., Sept. 16, 2014 /PRNewswire/ -- Micell Technologies, Inc.
Children and adolescents with autism have a surplus of synapses in the brain, and this excess is due to a slowdown in a normal brain “pruning” process during development, according to a study by neuroscientists at Columbia University Medical Center.
Cancer Research UK scientists have found a new use for an old drug by showing that it shrinks a particular type of pancreatic cancer tumor and stops it spreading.
-- Newly Issued US Patent Covers Medical Device Coating Process and Compositions -- DURHAM, N.C., July 9, 2014 /PRNewswire/ -- Micell Technologies, Inc.
HORSHOLM, Denmark, June 3, 2014 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) today announced the hiring of senior level management in preparation for potential U.S.
- To fire mitraille at.